Shiffman ML - Search Results

1

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.

Di Bisceglie AM, Stoddard AM, Dienstag JL, Shiffman ML, Seeff LB, Bonkovsky HL, Morishima C, Wright EC, Snow KK, Lee WM, Fontana RJ, Morgan TR, Ghany MG; HALT-C Trial Group. Di Bisceglie AM, et al. Among authors: shiffman ml. Hepatology. 2011 Apr;53(4):1100-8. doi: 10.1002/hep.24169. Hepatology. 2011. PMID: 21480316 Free PMC article. Clinical Trial.

2

Effect of NSAIDs on gallbladder bile composition.

Sterling RK, Shiffman ML, Sugerman HJ, Moore EW. Sterling RK, et al. Among authors: shiffman ml. Dig Dis Sci. 1995 Oct;40(10):2220-6. doi: 10.1007/BF02209010. Dig Dis Sci. 1995. PMID: 7587793

3

Flumazenil for hepatic coma: the elusive wake-up call?

Sterling RK, Shiffman ML, Schubert ML. Sterling RK, et al. Among authors: shiffman ml. Gastroenterology. 1994 Oct;107(4):1204-5. doi: 10.1016/0016-5085(94)90252-6. Gastroenterology. 1994. PMID: 7926473 No abstract available.

4

Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation.

Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP 3rd, Mills AS, Fisher RA, Posner MP. Shiffman ML, et al. Transplantation. 1994 Feb 27;57(4):526-32. Transplantation. 1994. PMID: 8116036

5

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.

Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP 3rd, Contos MJ, Mills AS, Edinboro LE, Poklis A. Shiffman ML, et al. Hepatology. 1994 Apr;19(4):933-40. Hepatology. 1994. PMID: 8138268

6

Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ, Contos MJ, Mills AS. Shiffman ML, et al. Hepatology. 1996 Jul;24(1):21-6. doi: 10.1002/hep.510240105. Hepatology. 1996. PMID: 8707264 Clinical Trial.

7

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, Luketic VA, Sanyal AJ, Mills AS, Garrett CT. Shiffman ML, et al. Hepatology. 1997 Sep;26(3):780-5. doi: 10.1002/hep.510260335. Hepatology. 1997. PMID: 9303513

8

Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.

Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ. Shiffman ML, et al. J Hepatol. 1998 Mar;28(3):382-9. doi: 10.1016/s0168-8278(98)80310-3. J Hepatol. 1998. PMID: 9551674 Clinical Trial.

9

Treatment of fulminant hepatic failure with intravenous prostaglandin E1.

Sterling RK, Luketic VA, Sanyal AJ, Shiffman ML. Sterling RK, et al. Among authors: shiffman ml. Liver Transpl Surg. 1998 Sep;4(5):424-31. doi: 10.1002/lt.500040501. Liver Transpl Surg. 1998. PMID: 9724481 Free article. Clinical Trial.

10

Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?

Sterling RK, Shiffman ML. Sterling RK, et al. Among authors: shiffman ml. Am J Gastroenterol. 1998 Sep;93(9):1405-7. doi: 10.1111/j.1572-0241.1998.01405.x. Am J Gastroenterol. 1998. PMID: 9732915 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters